On Wednesday, September 5th, OBIO hosted Toshio Sugano, the Chief Investment Officer of the Biomedical Development Board of Taiwan, who met with a collection of Canada’s most esteemed investors and some of its highest potential health science companies.
OBIO Hosts Delegation From National Cheng Kung University
OBIO Hosts Dr. Jonathan Shieh, Taipei Economic and Cultural Office and Government of Ontario officials
Last week, OBIO hosted a day of meetings with Dr. Jonathan Shieh, Executive Director, Science and Technology Division of the Taipei Economic and Cultural Office which brought Dr. Shieh together with officials from the Ontario government, Ministry of Economic Development, Job Creation and Trade, as well as high-potential Ontario health science companies.
Recapping 'How Do VCs Value Health Science Companies? From Valuation to Deal Structure'
On June 25th, OBIO organized a workshop with two industry leaders and provided a VC perspective on how they valuate start-up companies and on how this is translated into a deal structure, featuring presentations by Richard Meadows (General Partner, BioInnovation Capital Fund & OBIO Board Director) and Andy Haigh (COO, Adapsyn Bioscience).
Reviewing 'Formulating a Non-Dilutive Fundraising Strategy', Part 2 of OBIO's 'Building Your Early-Stage Strategy Toolbox' Event
Reviewing OBIO's Building Your Early-Stage Strategy Toolbox
Engaging with the FDA: An Insider's Perspective - Reviewing Dr. Yuan's Six Considerations
How to Develop Commercialization Strategies and Be Ready for Anything: Reviewing Dr. Brian Jahns Keynote
During his lively and highly engaging presentation on June 12, ‘Strategic Marketing & Commercialization Plans for Early Stage Companies,’ Dr. Brian Jahns (Senior VP, Commercial and Business Development at Trillium Therapeutics Inc) discussed approaches for developing strategies and the importance of scenario planning.
Medical Device Playbook Recap and Photo Gallery
On May 10, 2018, Medical Device Playbook 2018 Toronto, co-hosted by Starfish Medical and OBIO, drew a standing-room only audience of 170 health science industry professionals, from company executives, to QA, regulatory and R&D engineering experts from start-ups, manufacturers, consultancies, regulatory and academic organizations.
OBIO 2018 Leadership Event Recap and Launch of ‘Use It or Lose It’ Report
On May 3, OBIO welcomed health science leaders, CEOs and the investment community to the tenth annual OBIO Leadership Event, also saw the launch of Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap, OBIO's 2018 Industry Report.